Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK).
Saved in:
| Title: | Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). |
|---|---|
| Authors: | Rascol O; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Ory-Magne F; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Meissner WG; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand., Maltête D; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 1239, Rouen University Hospital, University of Rouen, INSERM, Rouen, France., Defebvre L; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Azulay JP; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France., Thobois S; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France.; Hospital Pierre Wertheimer, Hospices Civils de Lyon, University Lyon 1, INSERM, CNRS, Lyon, France., Houeto JL; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U 1094 EpiMaCT, CHU Limoges, INSERM, University of Limoges, Limoges, France., Thalamas C; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Sommet A; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Geny C; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France., Damier P; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, CIC 1413, Nantes University Hospital, Nantes University, INSERM, Nantes, France., Anheim M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U964/UMR7104, Strasbourg Institute of Neuroscience, Strasbourg, France.; Strasbourg University Hospital, University of Strasbourg, INSERM, CNRS, Strasbourg, France., Marquès A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 6602, Clermont-Ferrand University Hospital, CNRS, Clermont-Ferrand, France., Viallet F; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Aix-en-Provence Hospital, Aix-en-Provence, France., Giroud M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Dijon University Hospital, Dijon, France., Lefaucheur R; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France., Costentin G; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France., Spampinato U; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; INCIA-UMR 5287, CNRS, University of Bordeaux, Bordeaux, France., Samier-Foubert A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France., Carrière N; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Mutez E; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France., Mariani LL; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France., Eusebio A; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France., Prange S; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France., Benatru I; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre CIC1402, Poitiers University Hospital, INSERM, University of Poitiers, Poitiers, France., Charif M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France., Brefel-Courbon C; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Fabbri M; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Galitzky M; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Rousseau V; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Saubion A; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Catala H; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France., Ferreira JJ; Department of Clinical Pharmacology, Lisbon School of Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal and CNS - Campus Neurológico, Torres Vedras, Portugal., Burn DJ; Faculty of Medical Sciences, Newcastle University, The Medical School, Newcastle upon Tyne, UK., Corvol JC; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France. |
| Corporate Authors: | PREMANDYSK Study Group |
| Source: | Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2026 Mar; Vol. 41 (3), pp. 729-740. Date of Electronic Publication: 2025 Nov 29. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Multicenter Study |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 8610688 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-8257 (Electronic) Linking ISSN: 08853185 NLM ISO Abbreviation: Mov Disord Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41316871 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Rascol+O%22">Rascol O</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Ory-Magne+F%22">Ory-Magne F</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Meissner+WG%22">Meissner WG</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; Department of Medicine, University of Otago, Christchurch, and New Zealand Brain Research Institute, Christchurch, New Zealand.<br /><searchLink fieldCode="AU" term="%22Maltête+D%22">Maltête D</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 1239, Rouen University Hospital, University of Rouen, INSERM, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Defebvre+L%22">Defebvre L</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France.<br /><searchLink fieldCode="AU" term="%22Azulay+JP%22">Azulay JP</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Thobois+S%22">Thobois S</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France.; Hospital Pierre Wertheimer, Hospices Civils de Lyon, University Lyon 1, INSERM, CNRS, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Houeto+JL%22">Houeto JL</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U 1094 EpiMaCT, CHU Limoges, INSERM, University of Limoges, Limoges, France.<br /><searchLink fieldCode="AU" term="%22Thalamas+C%22">Thalamas C</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Sommet+A%22">Sommet A</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Geny+C%22">Geny C</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Damier+P%22">Damier P</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, CIC 1413, Nantes University Hospital, Nantes University, INSERM, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Anheim+M%22">Anheim M</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, U964/UMR7104, Strasbourg Institute of Neuroscience, Strasbourg, France.; Strasbourg University Hospital, University of Strasbourg, INSERM, CNRS, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Marquès+A%22">Marquès A</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, UMR 6602, Clermont-Ferrand University Hospital, CNRS, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Viallet+F%22">Viallet F</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Aix-en-Provence Hospital, Aix-en-Provence, France.<br /><searchLink fieldCode="AU" term="%22Giroud+M%22">Giroud M</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Dijon University Hospital, Dijon, France.<br /><searchLink fieldCode="AU" term="%22Lefaucheur+R%22">Lefaucheur R</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Costentin+G%22">Costentin G</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Rouen University Hospital, Rouen, France.<br /><searchLink fieldCode="AU" term="%22Spampinato+U%22">Spampinato U</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.; INCIA-UMR 5287, CNRS, University of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Samier-Foubert+A%22">Samier-Foubert A</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurodegenerative Disorders, Parkinson Expert Centre, IMNc, UMR 5293, Bordeaux University Hospital, CNRS, University of Bordeaux, Bordeaux, France.<br /><searchLink fieldCode="AU" term="%22Carrière+N%22">Carrière N</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France.<br /><searchLink fieldCode="AU" term="%22Mutez+E%22">Mutez E</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Movement Disorders, Parkinson Expert Centre, U1172-LilNCog, University Hospital of Lille, Lille University, Lille, France.<br /><searchLink fieldCode="AU" term="%22Mariani+LL%22">Mariani LL</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Eusebio+A%22">Eusebio A</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Pathology of Movement, Parkinson Expert Centre, UMR7289, AP-HM-Timone Hospital, University of Aix-Marseille, CNRS, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Prange+S%22">Prange S</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Lyon Neuroscience Research Centre, PATH-PARK Team U1028, UMR5292, Bron, France.<br /><searchLink fieldCode="AU" term="%22Benatru+I%22">Benatru I</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre CIC1402, Poitiers University Hospital, INSERM, University of Poitiers, Poitiers, France.<br /><searchLink fieldCode="AU" term="%22Charif+M%22">Charif M</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology and Geriatrics, Parkinson Expert Centre, Clinical Investigation Centre CIC 1411, CHU Montpellier, INSERM, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Brefel-Courbon+C%22">Brefel-Courbon C</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Fabbri+M%22">Fabbri M</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Galitzky+M%22">Galitzky M</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Rousseau+V%22">Rousseau V</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Saubion+A%22">Saubion A</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Catala+H%22">Catala H</searchLink>; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre, Clinical Investigation Centre CIC1436, University Hospital of Toulouse, INSERM, University of Toulouse 3, Toulouse, France.<br /><searchLink fieldCode="AU" term="%22Ferreira+JJ%22">Ferreira JJ</searchLink>; Department of Clinical Pharmacology, Lisbon School of Medicine, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal and CNS - Campus Neurológico, Torres Vedras, Portugal.<br /><searchLink fieldCode="AU" term="%22Burn+DJ%22">Burn DJ</searchLink>; Faculty of Medical Sciences, Newcastle University, The Medical School, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Corvol+JC%22">Corvol JC</searchLink>; French Clinical Research Network for Parkinson's Disease and Movement Disorders (NS-PARK), Toulouse, France.; Department of Neurology, Parkinson Expert Centre, Clinical Investigation Centre, Sorbonne Université, Paris Brain Institute - ICM, Assistance-Publique Hôpitaux de Paris, INSERM, CNRS, Paris, France. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22PREMANDYSK+Study+Group%22">PREMANDYSK Study Group</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228610688%22">Movement disorders : official journal of the Movement Disorder Society</searchLink> [Mov Disord] 2026 Mar; Vol. 41 (3), pp. 729-740. <i>Date of Electronic Publication: </i>2025 Nov 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Randomized Controlled Trial; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8610688 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1531-8257 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208853185%22">08853185 </searchLink><i>NLM ISO Abbreviation: </i>Mov Disord <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41316871 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/mds.70120 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 729 Titles: – TitleFull: Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK). Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Rascol O – PersonEntity: Name: NameFull: Ory-Magne F – PersonEntity: Name: NameFull: Meissner WG – PersonEntity: Name: NameFull: Maltête D – PersonEntity: Name: NameFull: Defebvre L – PersonEntity: Name: NameFull: Azulay JP – PersonEntity: Name: NameFull: Thobois S – PersonEntity: Name: NameFull: Houeto JL – PersonEntity: Name: NameFull: Thalamas C – PersonEntity: Name: NameFull: Sommet A – PersonEntity: Name: NameFull: Geny C – PersonEntity: Name: NameFull: Damier P – PersonEntity: Name: NameFull: Anheim M – PersonEntity: Name: NameFull: Marquès A – PersonEntity: Name: NameFull: Viallet F – PersonEntity: Name: NameFull: Giroud M – PersonEntity: Name: NameFull: Lefaucheur R – PersonEntity: Name: NameFull: Costentin G – PersonEntity: Name: NameFull: Spampinato U – PersonEntity: Name: NameFull: Samier-Foubert A – PersonEntity: Name: NameFull: Carrière N – PersonEntity: Name: NameFull: Mutez E – PersonEntity: Name: NameFull: Mariani LL – PersonEntity: Name: NameFull: Eusebio A – PersonEntity: Name: NameFull: Prange S – PersonEntity: Name: NameFull: Benatru I – PersonEntity: Name: NameFull: Charif M – PersonEntity: Name: NameFull: Brefel-Courbon C – PersonEntity: Name: NameFull: Fabbri M – PersonEntity: Name: NameFull: Galitzky M – PersonEntity: Name: NameFull: Rousseau V – PersonEntity: Name: NameFull: Saubion A – PersonEntity: Name: NameFull: Catala H – PersonEntity: Name: NameFull: Ferreira JJ – PersonEntity: Name: NameFull: Burn DJ – PersonEntity: Name: NameFull: Corvol JC IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1531-8257 Numbering: – Type: volume Value: 41 – Type: issue Value: 3 Titles: – TitleFull: Movement disorders : official journal of the Movement Disorder Society Type: main |
| ResultId | 1 |
